International law firm Pinsent Masons advised Teva Pharmaceuticals on its agreement to sell the assets and operations of Actavis in the UK and Ireland to Accord Healthcare Limited (a subsidiary of Intas Pharmaceuticals Ltd) for £603 million, subject to final approval from the European Commission.

Israel-headquartered Teva is a leading global pharmaceutical company and the world’s largest generic medicines producer, whose generic portfolio covers nearly every therapeutic area.

The Pinsent Masons team was led by life sciences partner, Allistair Booth and corporate partner Andrew Hornigold. The core team of Joe Sandys, Adam Coughlin, Jennifer Hopkins, Allison Sadick, Louise Fullwood, Zara Early, Tom Watkins, Christopher Sharp, Deborah Bould, Nick Stones, Eloise Walker, Satvi Veepa, Giles Warrington, Richard Snape, Ellie Okereke, Stephen Cochrane, Genna Oakes, Matthew Cooper, Fiona Kindness, Charles Waddell, Thilo Schneider, Ciaran Wilkinson, Joss Ealey and Cat Sibthrop played a pivotal role in getting the deal over the line.

Commenting on the deal, Allistair Booth, said: "We are delighted to have advised Teva on this deal at such an important time for the business.”